XyloCor Therapeutics
Operator of a bio-pharmaceutical firm intended to develop gene therapy for people with advanced coronary artery disease. The company's firm focuses on developing gene therapy to stimulate the formatio...
Valuation
$130M
Market implied
Share Price
N/A
Total Raised
$122M
Last Round
N/A